GILD vs PG · P/E 18, rev $29.44B vs P/E 25, rev $84.28B
Gilead Sciences Inc (GILD) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the GILD and PG stock pages for the full models.
Not investment advice.